Key Highlights
- VCI Global (NASDAQ:VCIG) was down 31.37% to USD 5.60 after a 1-for-18 reverse split.
- Huachen AI Parking Management Technology (NASDAQ:HCAI) was down 8.97% to USD 2.13 after a 1-for-20 split.
- Cellyan Biotechnology (NASDAQ:HKPD) was up 9.29% to USD 2.00, with a January 11, 2027 Nasdaq deadline.
- Dragonfly Energy (NASDAQ:DFLI) was up 9.45% to USD 1.99 after a 1-for-8 split.
- Sangrix (NASDAQ:SGRX) was up 9.08% to USD 0.8050, with 128 GPUs expected this week.
VCI Global (NASDAQ:VCIG) (down USD 2.56, 31.37%): A Sharp Drop After a 1-for-18 Split
VCI Global (NASDAQ:VCIG) was down 31.37% to USD 5.60 in pre-market trading on November 3, 2026. A 1-for-18 reverse split took effect at 12:01 a.m. Eastern Time on November 2, 2026, and no separate company announcement dated November 2 or November 3, 2026 was identified.
Shares outstanding were expected to fall from about 9,639,594 to about 535,533. The company said the split aims to meet the Nasdaq minimum bid price and position it for a potential "landmark institutional transaction", which it did not describe. It has consolidated before, with earlier splits of 1-for-60 and 1-for-15. With so few shares left, pre-market quotes can be unreliable.
Huachen AI Parking Management Technology (NASDAQ:HCAI) (down USD 0.2099, 8.97%): Giving Back an Earlier Advance
Huachen AI Parking Management Technology (NASDAQ:HCAI) was down 8.97% to USD 2.13 in pre-market trading on November 3, 2026, after a pre-market jump on November 2, 2026. No company announcement dated November 2 or November 3, 2026 was identified.
A 1-for-20 split took effect on October 23, 2026, cutting Class A shares from 10,379,942 to approximately 518,997 (company figure). It was the second split of 2026. First half 2026 Revenue was USD 2.47 million with Net Income of USD 51,273, down 96%. Cash was not identified in the sources reviewed. This Penny Stock carries volatility, thin Liquidity and dilution risk.
Cellyan Biotechnology (NASDAQ:HKPD) (up USD 0.1700, 9.29%): A Bounce Weeks After Its Split
Cellyan Biotechnology (NASDAQ:HKPD) was up 9.29% to USD 2.00 in pre-market trading on November 3, 2026, from an implied Monday close of about USD 1.83 (calculated). No company announcement dated October 30 to November 3, 2026 was identified.
A 1-for-20 split took effect on October 26, 2026. Nasdaq granted until January 11, 2027 to regain a closing bid of at least USD 1.00, and the company said there is no assurance it will. Fiscal 2025 revenue was USD 20.3 million, according to market data. A shelf registration for up to USD 200 million of securities could lead to dilution if used. It is a penny stock.
Dragonfly Energy (NASDAQ:DFLI) (up USD 0.1718, 9.45%): Battery Maker Bounces After a Reset
Dragonfly Energy (NASDAQ:DFLI) was up 9.45% to USD 1.99 in pre-market trading on November 3, 2026, from an implied Monday close of about USD 1.82 (calculated). No company announcement dated November 2 or November 3, 2026 was identified.
A 1-for-8 split took effect on October 12, 2026 to address Nasdaq Listing Rule 5550(a)(2). Second quarter 2026 net sales were USD 13.2 million, with management saying recreational vehicle softness persists. Full year 2025 revenue was USD 58.63 million against a net loss of USD 70.81 million, according to market data. Below USD 5, this penny stock carries dilution risk.
Sangrix (NASDAQ:SGRX) (up USD 0.0670, 9.08%): GPU Delivery Window and Another Split Ahead
Sangrix (NASDAQ:SGRX) was up 9.08% to USD 0.8050 in pre-market trading on November 3, 2026. No company announcement dated November 2 or November 3, 2026 was identified. Market data showed a gain of roughly 83.5% on October 30, 2026.
A company release dated October 16, 2026 said 128 Blackwell B300 GPUs are expected the week of November 3, 2026, depending on the manufacturer's logistics schedule. A filing summary listed a 1-for-10 split as scheduled for November 13, 2026, and noteholders converted Debt at USD 1.63 per share. This penny stock has a small float, and further dilution is possible.
Where Things Stand
These five stocks share a pattern: companies consolidating shares to address Nasdaq's USD 1 minimum bid price, then trading on very small share counts where large pre-market moves can occur without news. Sangrix, with its pending GPU delivery, and Cellyan, with its January 11, 2027 deadline, have the clearest dates to watch. Readers should also follow Nasdaq compliance letters, share issuance, and regular session Volume to see whether pre-market moves hold.






Please wait processing your request...